Jiangsu Hengrui Pharmaceuticals Co Ltd
600276.SS · Health Technology · Pharmaceuticals: Major · CN
20,636 employees · hengrui.com
About
Jiangsu Hengrui Pharmaceuticals Co Ltd, headquartered in Lianyungang, China, operates in the Health Care sector, specializing in Pharmaceuticals. The company researches, develops, manufactures, and sells a range of drugs including antineoplastic agents, angiomyocardiac medications, surgical drugs, contrast agents, antibiotics, and specialty infusions. With 20,636 employees, it serves both domestic and international markets, having been listed on the stock exchange in 2000.
Annual results
Reported figures, CNY · revenue up 12.3% in 2025
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2025 | 31.4B | 7.7B | 24.5% | — |
| 2024 | 28.0B | 6.3B | 22.6% | — |
| 2023 | 22.8B | 4.3B | 18.9% | — |
| 2022 | 21.3B | 3.9B | 18.4% | — |
| 2021 | 25.9B | 4.5B | 17.5% | — |
Dividends per share
600276.SS in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for Jiangsu Hengrui Pharmaceuticals Co Ltd are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.